SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal second quarter and six-month periods ended January 31, 2016.
Update – Fiscal Q2 2016
• Received FDA approvals for two Food Contact Notifications (FCN) to commercialize PURE Control® as a direct food contact processing aid to be applied directly onto fresh produce and raw poultry.
Update – Fiscal Q2 2016
• Received FDA approvals for two Food Contact Notifications (FCN) to commercialize PURE Control® as a direct food contact processing aid to be applied directly onto fresh produce and raw poultry.
